Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AMAP-102
/
AnaMar, AcurePharma
Welcome,
Profile
Billing
Logout
0 Diseases
0 Trials
0 Trials
1 News
||||||||||
AMAP-102
/
AnaMar, AcurePharma
New P2 trial:
A study to determine the safety, tolerability and efficacy of AMAP102 compared to placebo in patients with osteoarthritis
(EUDRACT) - Jul 17, 2012
P2
, N=45, Ongoing,
Sponsor: AnaMar AB